Insmed Inc banner

Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 139.4 USD -3.09% Market Closed
Market Cap: $29.7B

Profitability Summary

Insmed Inc's profitability score is 30/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

30/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

30/100
Profitability
Score
30/100
Profitability
Score

Margins

Earnings Waterfall
Insmed Inc

Margins Comparison
Insmed Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Insmed Inc
NASDAQ:INSM
29.9B USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
402.5B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
203.5B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
181.2B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
125.1B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.9B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
68.7B AUD
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.2B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Insmed Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Insmed Inc
NASDAQ:INSM
29.9B USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
402.5B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
203.5B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
181.2B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
125.1B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.9B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
68.7B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.2B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Insmed Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett